|
|
|
|
|
|
by maxerickson
3586 days ago
|
|
|
They should allow reasonably safe products that are among the best available options. So if people can use an Epipen more reliably than they can prepare an injection, allow it to be marketed. If someone with a history of anaphylaxis is better off with an Epipen than they are with no treatment at all, allow it to be marketed. |
|
|